AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Balance Sheet 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B | 1.01B |
| Cash & Equivalents | 128.5M | 156.3M | 133.3M | 386.5M | 476.1M | 594.1M |
| Liabilities | ||||||
| Total Liabilities | 390.0M | 304.5M | 335.8M | 307.6M | 292.8M | 175.0M |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | 966.9M | 1.06B | 1.15B | 1.23B | 1.03B | 830.5M |
AbCellera Biologics Inc. Balance Sheet — FAQ
AbCellera Biologics Inc. (ABCL) balance sheet over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's balance sheet history?
The chart and table above show AbCellera Biologics Inc.'s balance sheet by year and by quarter, including the growth rate.